79
Views
3
CrossRef citations to date
0
Altmetric
Special Report

Genetics of cognitive deficits in ADHD: clues for novel treatment methods

, &
Pages 553-561 | Published online: 09 Jan 2014

References

  • Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, DC, USA (1995).
  • Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJ. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol. Psychiatry57(11), 1224–1230 (2005).
  • Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry160(4), 636–645 (2003).
  • Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci.3(8), 617–628 (2002).
  • Bellgrove MA, Hawi Z, Gill M, Robertson IH. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex42(6), 838–845 (2006).
  • Douglas VI. Stop, look and listen: the problem of sustained attention and impusle control in hyperactive and normal children. Can. J. Behav. Sci.4, 259–282 (1972).
  • Robertson IH, Manly T, Andrade J, Baddeley BT, Yiend J. ‘Oops!’: performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia35(6), 747–758 (1997).
  • Shallice T, Marzocchi GM, Coser S et al. Executive function profile of children with attention deficit hyperactivity disorder. Dev. Neuropsychol.21(1), 43–71 (2002).
  • O’Connell RG, Bellgrove MA, Dockree PM, Robertson IH. Reduced electrodermal response to errors predicts poor sustained attention performance in attention deficit hyperactivity disorder. Neuroreport15(16), 2535–2538 (2004).
  • Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol. Psychiatry44(4), 260–268 (1998).
  • Epstein JN, Johnson DE, Varia IM, Conners CK. Neuropsychological assessment of response inhibition in adults with ADHD. J. Clin. Exp. Neuropsychol.23(3), 362–371 (2001).
  • Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of ADHD: a meta-analytic review. Biol. Psychiatry57(11), 1336–1346 (2005).
  • Manly T, Owen AM, McAvenue L et al. Enhancing the sensitivity of a sustained attention task to frontal damage: convergent clinical and functional imaging evidence. Neurocase9(4), 340–349 (2003).
  • Pardo JV, Fox PT, Raichle ME. Localisation of a human system for sustained attention by positron emission tomography. Nature349, 61–64 (1991).
  • Sturm W, de Simone A, Krause BJ et al. Functional anatomy of intrinsic alertness: evidence for a fronto–parietal–thalamic–brainstem network in the right hemisphere. Neuropsychologia37(7), 797–805 (1999).
  • Sturm W, Willmes K. On the functional neuroanatomy of intrinsic and phasic alertness. Neuroimage14, S76–S84 (2001).
  • Sturm W, Longoni F, Fimm B et al. Network for auditory intrinsic alertness: a PET study. Neuropsychologia42(5), 563–568 (2004).
  • Coull JT, Buchel C, Friston KJ, Frith CD. Noradrenergically mediated plasticity in a human attentional neuronal network. Neuroimage10, 705–715 (1999).
  • Weissman DH, Roberts KC, Visscher KM, Woldorff MG. The neural bases of momentary lapses in attention. Nat. Neurosci.9(7), 971–978 (2006).
  • Paus T, Zatorre RJ, Hofle N et al. Time-related changes in neural systems underlying attention and arousal during the performance of an auditory vigilance task. J. Cogn. Neurosci.9(3), 392–408 (1997).
  • Marrocco RT, Witte EA, Davidson MC. Arousal systems. Curr. Opin. Neurobiol.4, 166–170 (1994).
  • Smith A, Nutt D. Noradrenaline and attention lapses. Nature380, 291 (1996).
  • Wilkins AJ, Shallice T, McCarthy R. Frontal lesions and sustained attention. Neuropsychologia25(2), 359–365 (1987).
  • O’Connell RG, Bellgrove MA, Dockree PM, Robertson IH. Cognitive remediation in ADHD: effects of periodic non-contingent alerts on sustained attention to response. Neuropsychol. Rehabil.16(6), 653–665 (2006).
  • Stuss DT, Murphy KJ, Binns MA, Alexander MP. Staying on the job: the frontal lobes control individual performance variability. Brain126(Pt 11), 2363–2380 (2003).
  • Bellgrove MA, Hester R, Garavan H. The functional neuroanatomical correlates of response variability: evidence from a response inhibition task. Neuropsychologia42(14), 1910–1916 (2004).
  • Castellanos FX, Sonuga-Barke EJS, Scheres A et al. Varieties of attention deficit/hyperactivity disorder-related intra-individual variability. Biol. Psychiatry57(11), 1416–1423 (2005).
  • Johnson KA, Kelly SP, Bellgrove MA et al. Response variability in attention deficit hyperactivity disorder: evidence for neuropsychological heterogeneity. Neuropsychologia45(4), 630–638 (2007).
  • Polderman TJ, Gosso MF, Posthuma D et al. A longitudinal twin study on IQ, executive functioning, and attention problems during childhood and early adolescence. Acta Neurol. Belg.106(4), 191–207 (2006).
  • Groot AS, de Sonneville LM, Stins JF, Boomsma DI. Familial influences on sustained attention and inhibition in preschoolers. J. Child Psychol. Psychiatry45(2), 306–314 (2004).
  • Polderman TJ, Posthuma D, De Sonneville LM et al. Genetic analyses of the stability of executive functioning during childhood. Biol. Psychol.76(1–2), 11–20 (2007).
  • Slaats-Willemse D, Swaab-Barneveld H, De Sonneville L, Buitelaar J. Familial clustering of executive functioning in affected sibling pair families with ADHD. J. Am. Acad. Child Adolesc. Psychiatry44(4), 385–391 (2005).
  • Slaats-Willemse D, Swaab-Barneveld H, De Sonneville L, Van Der Meulen E, Buitelaar J. Deficient Response inhibition as a cognitive endophenotype of ADHD. J. Am. Acad. Child Adolesc. Psychiatry42(10), 1242–1248 (2003).
  • Nigg JT, Swanson JM, Hinshaw SP. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response, and results for parents. Neuropsychologia35(2), 165–176 (1997).
  • Kuntsi J, Stevenson J. Psychological mechanisms in hyperactivity: II. The role of genetic factors. J. Child Psychol. Psychiatry42(2), 211–219 (2001).
  • Kuntsi J, Rogers H, Swinard G et al. Reaction time, inhibition, working memory and ‘delay aversion’ performance: genetic influences and their interpretation. Psychol. Med.36, 1613–1624 (2006).
  • Andreou P, Neale BM, Chen W et al. Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol. Med.37, 1703–1715 (2007).
  • Loo SK, Specter E, Smolen A et al. Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J. Am. Acad. Child Adolesc. Psychiatry42(8), 986–993 (2003).
  • Bellgrove MA, Gill M, Hawi Z, Kirley A, Robertson IH. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia43(13), 1847–1857 (2005).
  • Cook EH, Stein MA, Krasowski MD et al. Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet.56, 993–998 (1995).
  • Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry4, 192–196 (1999).
  • Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol. Psychiatry2, 311–313 (1997).
  • Brookes KJ, Mill J, Guindalini C et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch. Gen. Psychiatry63(1), 74–81 (2006).
  • Roman T, Schmitz M, Polanczyk GV et al. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-b-hydroxylase gene. Am. J. Med. Genet.114(2), 154–158 (2002).
  • Arnsten AFT. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn. Sci.2(11), 436–447 (1998).
  • Posner MI, Peterson SE. The attention system of the human brain. Annu. Rev. Neurosci.13, 35–42 (1990).
  • Aston-Jones G, Rajkowski J, Ivanova S, Usher M, Cohen J. Neuromodulation and cognitive performance: recent studies of noradrenergic locus ceruleus neurons in behaving monkeys. Adv. Pharmacol.42, 755–759 (1998).
  • Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J. Am. Acad. Child Adolesc. Psychiatry35(3), 264–272 (1996).
  • Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry158(7), 1052–1057 (2001).
  • Johnson KA, Kelly SP, Robertson IH et al. Absence of the 7-repeat variant of the DRD4 VNTR is associated with drifting sustained attention in children with ADHD but not in controls. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2008) (Epub ahead of print).
  • Waldman ID. Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder. Biol. Psychiatry57(11), 1347–1356 (2005).
  • Swanson J, Oosterlaan J, Murias M et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc. Natl Acad. Sci. USA97(9), 4754–4759 (2000).
  • Asghari V, Sanyal S, Buchwaldt S et al. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem.65(3), 1157–1165 (1995).
  • Jovanovic V, Guan HC, Van Tol HH. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics9(5), 561–568 (1999).
  • van Mourik R, Oosterlaan J, Sergeant JA. The Stroop revisited: a meta-analysis of interference control in AD/HD. J. Child Psychol. Psychiatry46(2), 150–165 (2005).
  • Lansbergen MM, Kenemans JL, van Engeland H. Stroop interference and attention-deficit/hyperactivity disorder: a review and meta-analysis. Neuropsychology21(2), 251–262 (2007).
  • Posner MI, Cohen Y. Components of visual orienting. In: Attention and Performance. Bouma H, Bouwhuis DG (Eds). Lawrence Erlbaum, London, UK (1984).
  • Huang-Pollock CL, Nigg JT. Searching for the attention deficit in attention deficit hyperactivity disorder: the case for visuospatial orienting. Clin. Psychol. Rev.23, 801–830 (2003).
  • Swanson JM, Posner M, Potkin S et al. Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J. Child Neurol.6(Suppl.) S119–S127 (1991).
  • Carter CS, Krener P, Chaderjian M, Northcutt C, Wolfe V. Asymmetrical visual-spatial attentional performance in ADHD: evidence for a right hemispheric deficit. Biol. Psychiatry37(11), 789–797 (1995).
  • Epstein JN, Conners CK, Erhardt D, March JS, Swanson JM. Asymmetrical hemispheric control of visual–spatial attention in adults with attention deficit hyperactivity disorder. Neuropsychology11(4), 467–473 (1997).
  • McDonald S, Bennett KM, Chambers H, Castiello U. Covert orienting and focusing of attention in children with attention deficit hyperactivity disorder. Neuropsychologia37(3), 345–356 (1999).
  • Unilateral Neglect: Clinical and Experimental Studies. Robertson IH, Marshall JC (Eds). Lawrence Erlbaum and Associates, NJ, USA (1993).
  • Corbetta M, Kincade JM, Ollinger JM, McAvoy MP, Shulman GL. Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nat. Neurosci.3(3), 292–297 (2000).
  • Voeller KK, Heilman KM. Attention deficit disorder in children: a neglect syndrome? Neurology38(5), 806–808 (1988).
  • Sheppard DM, Bradshaw JL, Mattingley JB, Lee P. Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder. J. Neurol. Neurosurg. Psychiatr.66, 57–63 (1999).
  • Geeraerts S, Lafosse C, Vaes N, Vandenbussche E, Verfaillie K. Dysfunction of right-hemisphere attentional networks in attention deficit hyperactivity disorder. J. Clin. Exp. Neuropsychol.30(1), 42–52 (2008).
  • Maruff P, Hay D, Malone V, Currie J. Asymmetries in the covert orienting of visual spatial attention in schizophrenia. Neuropsychologia33(10), 1205–1223 (1995).
  • Fleet WS, Valenstein E, Watson RT, Heilman KM. Dopamine agonist therapy for neglect in humans. Neurology37(11), 1765–1770 (1987).
  • Fan J, Wu Y, Fossella JA, Posner MI. Assessing the heritability of attentional networks. BMC Neurosci.2, 14 (2001).
  • Bellgrove MA, Hawi Z, Kirley A et al. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Neuropsychopharmacology30(12), 2290–2297 (2005).
  • Bellgrove MA, Barry E, Johnson KA et al. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD. Neuropsychopharmacology (2007) (Epub ahead of print).
  • Fink GR, Marshall JC, Shah NJ et al. Line bisection judgments implicate right parietal cortex and cerebellum as assessed by fMRI. Neurology54(6), 1324–1331 (2000).
  • Lewis DA, Melchitzky DS, Sesack SR et al. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol.432(1), 119–136 (2001).
  • Bellgrove MA, Chambers CD, Johnson KA et al. Dopaminergic genotype biases spatial attention in healthy children. Mol. Psychiatry12(8), 786–792 (2007).
  • O’Connell RG, Bellgrove MA, Dockree PM et al. Self-alert training: volitional modulation of autonomic arousal improves sustained attention. Neuropsychologia (2007) (Epub ahead of print).
  • Robertson IH, Tegnér R, Tham K, Lo A, Nimmo-Smith I. Sustained attention training for unilateral neglect: theoretical and rehabilitation implications. J. Clin. Exp. Neuropsychol.17(3), 416–430 (1995).
  • Klingberg T, Fernell E, Olesen PJ et al. Computerized training of working memory in children with ADHD – a randomized, controlled trial. J. Am. Acad. Child Adolesc. Psychiatry44(2), 177–186 (2005).
  • Olesen PJ, Westerberg H, Klingberg T. Increased prefrontal and parietal activity after training of working memory. Nat. Neurosci.7(1), 75–79 (2004).
  • Kirley A, Lowe N, Hawi Z et al. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am. J. Med. Genet.121B(1), 50–54 (2003).
  • Stein MA, Waldman ID, Sarampote CS et al. Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology30(7), 1374–1382 (2005).
  • Roman T, Szobot C, Martins S et al. Dopamine transporter gene and response to methlphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics12, 497–499 (2002).
  • Gilbert DL, Wang Z, Sallee FR et al. Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain129(Pt 8), 2038–2046 (2006).
  • Angold A, Costello J, Erkanli A. Comorbidity. J. Child Psychol. Psychiatry40, 57–97 (1999).
  • Vance A, Arduca Y, Sanders M. The associations of oppositional defiant behaviour in children with attention deficit hyperactivity disorder, combined type (ADHD-CT). J. Affect. Disord.86, 329–333 (2005).
  • Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J. Am. Acad. Child Adolesc. Psychiatry36, 1065–1079 (1997).
  • Sanders M, Arduca Y, Karamitsios M, Boots M, Vance A. Characteristics of anxiety disorders in medication naive, clinically referred children with attention deficit hyperactivity disorder, combined type (ADHD-CT) and dysthymic disorder (DD). Aust. NZ J. Psychiatry39, 359–365 (2005).
  • Vance ALA, Harris K, Boots M et al. Attention deficit hyperactivity disorder, combined type (ADHD-CT) with and without dysthymic disorder: characteristics of parent and child reported anxiety. Aust. NZ J. Psychiatry37, 563–569 (2003).
  • Vance ALA, Luk ESL. Heart of the matter review: attention deficit hyperactivity disorder: progress and controversies. Aust. N. Z. J. Psychiatry34, 719–730 (2000).
  • Barnett R, Maruff P, Vance A. An investigation of visuospatial memory impairment in children with ADHD, combined type. Psych. Med.35, 1433–1443 (2005).
  • Mollica C, Maruff P, Vance A. The effects of age and practice on the consistency of performance on a computerised assessment of cognitive change in children. J. Child Neuropsych.11, 303–310 (2005)
  • Barnett R, Vance ALA, Maruff P, Luk SL, Costin J, Pantelis C. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psych. Med.31, 1107–1115 (2001).
  • Vance ALA. Attention deficit hyperactivity disorder: towards an innovative developmental model. Aust. NZ J. Psychiatry36, 485–487 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.